SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025
Rhea-AI Summary
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company specializing in data-driven medicine, has scheduled its second quarter 2025 financial results announcement for August 5, 2025, before U.S. markets open.
The company will host a conference call to discuss the results and business outlook at 8:00 AM EDT / 2:00 PM CET. Investors can access the live webcast through the SOPHiA GENETICS Investor Relations Website, where a replay will also be available after the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, SOPH declined 1.72%, reflecting a mild negative market reaction. Argus tracked a trough of -2.4% from its starting point during tracking. This price movement removed approximately $4M from the company's valuation, bringing the market cap to $249M at that time.
Data tracked by StockTitan Argus on the day of publication.
The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data – including genomics, radiomics, clinical, biological, and digital pathology data – to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-second-quarter-2025-on-august-5-2025-302509646.html
SOURCE SOPHiA GENETICS